Evaluation of Potential Neuroprotective Effects of Vanillin Against MPP+/MPTP-Induced Dysregulation of Dopaminergic Regulatory Mechanisms in SH-SY5Y Cells and a Mouse Model of Parkinson’s Disease

[1]  O. Oladimeji.  A Cycloalkanol from Derivatization Studies on Vanillin: Evaluation of Antioxidant Activity of Obtained Derivatives , 2022, Journal of Pharmaceutical Research Science & Technology.

[2]  M. Rizvi,et al.  Naringenin alleviates paraquat-induced dopaminergic neuronal loss in SH-SY5Y cells and a rat model of Parkinson's disease , 2021, Neuropharmacology.

[3]  M. Nazıroğlu,et al.  Protective role of selenium on MPP+ and homocysteine-induced TRPM2 channel activation in SH-SY5Y cells , 2021, Journal of receptor and signal transduction research.

[4]  D. Cahill,et al.  Vanillin: a review on the therapeutic prospects of a popular flavouring molecule , 2021, Advances in Traditional Medicine.

[5]  C. N. Mat Taib,et al.  MPTP-induced mouse model of Parkinson’s disease: A promising direction for therapeutic strategies , 2020, Bosnian journal of basic medical sciences.

[6]  D. Hiss,et al.  Regulation of AKT/AMPK signaling, autophagy and mitigation of apoptosis in Rutin-pretreated SH-SY5Y cells exposed to MPP+ , 2020, Metabolic Brain Disease.

[7]  K. Prajapati,et al.  Piperine-Coated Gold Nanoparticles Alleviate Paraquat-Induced Neurotoxicity in Drosophila melanogaster. , 2020, ACS chemical neuroscience.

[8]  J. Weber,et al.  The Pathology of Parkinson’s Disease and Potential Benefit of Dietary Polyphenols , 2020, Molecules.

[9]  K. Alzoubi,et al.  The beneficial effect of vanillin on 6-hydroxydopamine rat model of Parkinson's disease. , 2020, Restorative neurology and neuroscience.

[10]  A. Giordano,et al.  Vanillin Prevents Doxorubicin-Induced Apoptosis and Oxidative Stress in Rat H9c2 Cardiomyocytes , 2020, Nutrients.

[11]  Yong Seok Park,et al.  BAX-dependent mitochondrial pathway mediates the crosstalk between ferroptosis and apoptosis , 2020, Apoptosis.

[12]  J. Woodgett,et al.  GSK-3β Contributes to Parkinsonian Dopaminergic Neuron Death: Evidence From Conditional Knockout Mice and Tideglusib , 2020, Frontiers in Molecular Neuroscience.

[13]  Quanbin Zhang,et al.  Protective Effect of Fucoidan against MPP+-Induced SH-SY5Y Cells Apoptosis by Affecting the PI3K/Akt Pathway , 2020, Marine drugs.

[14]  Fei Zou,et al.  Poly (ADP‐ribose) polymerase 1 inhibition prevents neurodegeneration and promotes α‐synuclein degradation via transcription factor EB‐dependent autophagy in mutant α‐synucleinA53T model of Parkinson's disease , 2020, Aging cell.

[15]  K. Fukunaga,et al.  Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia , 2020, International journal of molecular sciences.

[16]  M. Mccarty,et al.  Nutraceuticals Targeting Generation and Oxidant Activity of Peroxynitrite May Aid Prevention and Control of Parkinson’s Disease , 2020, International journal of molecular sciences.

[17]  E. Tan,et al.  Historical Perspective: Models of Parkinson’s Disease , 2020, International journal of molecular sciences.

[18]  S. Srivastav,et al.  A selective D2 dopamine receptor agonist alleviates depression through up-regulation of tyrosine hydroxylase and increased neurogenesis in hippocampus of the prenatally stressed rats , 2020, Neurochemistry International.

[19]  A. Lang,et al.  Initiation of pharmacological therapy in Parkinson's disease: when, why, and how , 2020, The Lancet Neurology.

[20]  M. Islam,et al.  Vanillin and vanillic acid modulate antioxidant defense system via amelioration of metabolic complications linked to Fe2+-induced brain tissues damage , 2020, Metabolic Brain Disease.

[21]  G. Blandino,et al.  Wild type- and mutant p53 proteins in mitochondrial dysfunction: emerging insights in cancer disease. , 2020, Seminars in cell & developmental biology.

[22]  Nasser S M Ismail,et al.  Therapeutic Potential of Vanillin and its Main Metabolites to Regulate the Inflammatory Response and Oxidative Stress. , 2019, Mini reviews in medicinal chemistry.

[23]  J. Hecksher-Sørensen,et al.  Quantitative whole-brain 3D imaging of tyrosine hydroxylase-labeled neuron architecture in the mouse MPTP model of Parkinson's disease , 2019, Disease Models & Mechanisms.

[24]  K. Double,et al.  Expression of tyrosine hydroxylase isoforms and phosphorylation at serine 40 in the human nigrostriatal system in Parkinson's disease , 2019, Neurobiology of Disease.

[25]  P. Dharmasaroja,et al.  Metformin restores the mitochondrial membrane potentials in association with a reduction in TIMM23 and NDUFS3 in MPP+-induced neurotoxicity in SH-SY5Y cells , 2019, EXCLI journal.

[26]  X. Shao,et al.  Hepatic DNA Damage Induced by Electronic Cigarette Exposure Is Associated With the Modulation of NAD+/PARP1/SIRT1 Axis , 2019, Front. Endocrinol..

[27]  C. Sue,et al.  New insights into the complex role of mitochondria in Parkinson’s disease , 2019, Progress in Neurobiology.

[28]  Xia Li,et al.  A vanillin derivative suppresses the growth of HT29 cells through the Wnt/&bgr;‐catenin signaling pathway , 2019, European journal of pharmacology.

[29]  F. Facchiano,et al.  Beneficial Role of Phytochemicals on Oxidative Stress and Age-Related Diseases , 2019, BioMed research international.

[30]  Joseph R. Scarpa,et al.  Parkinson’s Disease is Associated with Dysregulations of a Dopamine-Modulated Gene Network Relevant to Sleep and Affective Neurobehaviors in the Striatum , 2019, Scientific Reports.

[31]  N. Zeghal,et al.  Beneficial role of vanillin, a polyphenolic flavoring agent, on maneb-induced oxidative stress, DNA damage, and liver histological changes in Swiss albino mice , 2019, Human & experimental toxicology.

[32]  B. Bloem,et al.  The Emerging Evidence of the Parkinson Pandemic , 2018, Journal of Parkinson's disease.

[33]  J. Blesa,et al.  Advances in Parkinson’s Disease: 200 Years Later , 2018, Front. Neuroanat..

[34]  E. Farombi,et al.  Ethanol Exacerbates Manganese-Induced Neurobehavioral Deficits, Striatal Oxidative Stress, and Apoptosis Via Regulation of p53, Caspase-3, and Bax/Bcl-2 Ratio-Dependent Pathway , 2018, Biological Trace Element Research.

[35]  J. Pascal.  The comings and goings of PARP-1 in response to DNA damage. , 2018, DNA repair.

[36]  J. McCubrey,et al.  Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging , 2018, Expert opinion on therapeutic targets.

[37]  M. Sakharkar,et al.  Cocoa beans improve mitochondrial biogenesis via PPARγ/PGC1α dependent signalling pathway in MPP+ intoxicated human neuroblastoma cells (SH-SY5Y)† , 2018, Nutritional neuroscience.

[38]  C. Sampaio,et al.  International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease , 2018, Movement disorders : official journal of the Movement Disorder Society.

[39]  R. Duvoisin,et al.  Effects of Sub-Chronic MPTP Exposure on Behavioral and Cognitive Performance and the Microbiome of Wild-Type and mGlu8 Knockout Female and Male Mice , 2018, Front. Behav. Neurosci..

[40]  Kazuto Kobayashi,et al.  Human tyrosine hydroxylase in Parkinson’s disease and in related disorders , 2018, Journal of Neural Transmission.

[41]  Chun Cui,et al.  Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson’s disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway , 2018, Brain, Behavior, and Immunity.

[42]  Morakot Sroyraya,et al.  The antioxidant and neurochemical activity of Apium graveolens L. and its ameliorative effect on MPTP-induced Parkinson-like symptoms in mice , 2018, BMC Complementary and Alternative Medicine.

[43]  Seungjoon Park,et al.  IGF-1 protects SH-SY5Y cells against MPP+-induced apoptosis via PI3K/PDK-1/Akt pathway , 2018, Endocrine connections.

[44]  X. Gu,et al.  Achyranthes bidentata polypeptide protects dopaminergic neurons from apoptosis in Parkinson's disease models both in vitro and in vivo , 2018, British journal of pharmacology.

[45]  Linfu Li,et al.  The Key Roles of GSK-3β in Regulating Mitochondrial Activity , 2017, Cellular Physiology and Biochemistry.

[46]  P. Maiti,et al.  Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments , 2017, Translational Neurodegeneration.

[47]  Zishan Wang,et al.  Dynamic Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson's Disease , 2017, Parkinson's disease.

[48]  D. Choi,et al.  Atractylenolide-I Protects Human SH-SY5Y Cells from 1-Methyl-4-Phenylpyridinium-Induced Apoptotic Cell Death , 2017, International journal of molecular sciences.

[49]  Melissa K. Edler,et al.  Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss , 2017, Neurotoxicology.

[50]  Wei Liu,et al.  miR-135b Plays a Neuroprotective Role by Targeting GSK3β in MPP+-Intoxicated SH-SY5Y Cells , 2017, Disease markers.

[51]  J. Langston,et al.  The MPTP Story , 2017, Journal of Parkinson's disease.

[52]  Dong Liu,et al.  Vanillin Protects Dopaminergic Neurons against Inflammation-Mediated Cell Death by Inhibiting ERK1/2, P38 and the NF-κB Signaling Pathway , 2017, International journal of molecular sciences.

[53]  K. Faisal,et al.  Low-dose acute vanillin is beneficial against harmaline-induced tremors in rats , 2017, Neurological research.

[54]  A. Mironov.  Stereological morphometric grids for ImageJ , 2017, Ultrastructural pathology.

[55]  Mandar S Jog,et al.  An update on the diagnosis and treatment of Parkinson disease , 2016, Canadian Medical Association Journal.

[56]  T. Manivasagam,et al.  Vanillin Attenuated Behavioural Impairments, Neurochemical Deficts, Oxidative Stress and Apoptosis Against Rotenone Induced Rat Model of Parkinson’s Disease , 2016, Neurochemical Research.

[57]  C. Cobb,et al.  Oxidative and nitrative stress in neurodegeneration , 2015, Neurobiology of Disease.

[58]  T. Manivasagam,et al.  Neurosupportive Role of Vanillin, a Natural Phenolic Compound, on Rotenone Induced Neurotoxicity in SH-SY5Y Neuroblastoma Cells , 2015, Evidence-based complementary and alternative medicine : eCAM.

[59]  L. Mosca,et al.  PARP-1 involvement in neurodegeneration: A focus on Alzheimer’s and Parkinson’s diseases , 2015, Mechanisms of Ageing and Development.

[60]  Dick F. Swaab,et al.  Phenotypic Characterization of Retinoic Acid Differentiated SH-SY5Y Cells by Transcriptional Profiling , 2013, PloS one.

[61]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[62]  Yanjun Zeng,et al.  Overview of tyrosine hydroxylase in Parkinson's disease. , 2012, CNS & neurological disorders drug targets.

[63]  S. Przedborski,et al.  Protocol for the MPTP mouse model of Parkinson's disease , 2007, Nature Protocols.

[64]  K Indira Priyadarsini,et al.  Inhibition of peroxynitrite-mediated reactions by vanillin. , 2004, Journal of agricultural and food chemistry.

[65]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[66]  N. Ogawa,et al.  Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion , 1997, Journal of Neuroscience Methods.

[67]  H. J. G. GUNDERSEN,et al.  Some new, simple and efficient stereological methods and their use in pathological research and diagnosis , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[68]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[69]  S. T. Abdullahi,et al.  Evaluation of Antioxidant Activity of Obtained Derivatives of Vanillin , 2022 .

[70]  Linchi Rani,et al.  Emerging concepts of mitochondrial dysfunction in Parkinson's disease progression: Pathogenic and therapeutic implications. , 2019, Mitochondrion.

[71]  F. Ahmad,et al.  Evidence of vanillin binding to CAMKIV explains the anti-cancer mechanism in human hepatic carcinoma and neuroblastoma cells , 2017, Molecular and Cellular Biochemistry.

[72]  D. Langford,et al.  Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. , 2013, Methods in molecular biology.

[73]  G. Meredith,et al.  MPTP mouse models of Parkinson's disease: an update. , 2011, Journal of Parkinson's disease.